Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Group 1 – People with melanoma that can be surgically removed (Resectable Stage II or III):
- People diagnosed with stage IIA, IIB, IIC, or III melanoma that can be surgically removed, confirmed by a tissue test (biopsy)
- People who have not yet received any systemic (whole-body) treatment for their stage II or III melanoma
- People whose tumour tissue samples can be collected and stored at a specialist biological storage centre (this is optional, not required)
- People aged 18 or older
- People who have agreed to take part and signed a consent form
Group 2 – People with advanced or inoperable melanoma (Unresectable Stage III, Stage IV, or inoperable primary tumour):
- People diagnosed with advanced melanoma confirmed by a tissue test (biopsy), where the melanoma cannot be surgically removed, or is stage IV (any type), or involves an inoperable primary tumour
- People who have not previously received systemic (whole-body) treatment for their advanced melanoma, though prior adjuvant (preventive/follow-up) treatment is allowed
- People who are receiving or have received a neoadjuvant (pre-surgery) treatment in exceptional circumstances (confirm with trial site)
- People whose tumour tissue samples can be collected and stored at a specialist biological storage centre (this is optional, not required)
- People aged 18 or older
- People who have agreed to take part and signed a consent form
Who may not be able to join:
Group 1:
- People who have declined to participate
- People whose melanoma started in the eye (choroidal melanoma)
- People with stage I melanoma that can be surgically removed
- People with stage IV melanoma, an inoperable primary tumour, or inoperable stage III melanoma
- People who are under legal guardianship or trusteeship
Group 2:
- People who have declined to participate
- People whose melanoma started in the eye (choroidal melanoma)
- People with stage I, II, or III melanoma that can be surgically removed
- People who are under legal guardianship or trusteeship
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Celeste Lebbe, MD, PhD, AP-HP, Hopital Saint-Louis, centre d'oncodermatologie, Paris
Phone: +33142494679
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.